| 27th Feb 2025 4:30 pm |
RNS |
PDS: up to $22mn Registered Direct Offering |
| 5th Feb 2025 3:24 pm |
RNS |
PDS Biotech reaffirms guidance for clinical trial |
| 3rd Feb 2025 7:00 am |
RNS |
ProAxsis: Status Update and Proposed Fundraise |
| 6th Jan 2025 4:42 pm |
RNS |
TR-1 |
| 31st Dec 2024 7:05 am |
RNS |
Grant of Share Options |
| 31st Dec 2024 7:00 am |
RNS |
Q-Bot Fundraising |
| 12th Dec 2024 4:49 pm |
RNS |
TR-1 |
| 9th Dec 2024 7:00 am |
RNS |
Wanda Health Fundraising |
| 5th Dec 2024 7:00 am |
RNS |
Close of Fundraising and Result of Retail Offer |
| 3rd Dec 2024 1:24 pm |
RNS |
Result of Subscription |
| 3rd Dec 2024 7:05 am |
RNS |
WRAP Retail Offer |
| 3rd Dec 2024 7:00 am |
RNS |
Proposed Subscription and Retail Offer; Update |
| 14th Nov 2024 3:59 pm |
RNS |
Replacement RNS: PDS: Update, 3rd Quarter Results |
| 14th Nov 2024 3:23 pm |
RNS |
PDS: Clinical Programs Update, 3rd Quarter Results |
| 8th Oct 2024 7:00 am |
RNS |
Director/PDMR Shareholding |
| 3rd Oct 2024 7:00 am |
RNS |
Director/PDMR Shareholding |
| 2nd Oct 2024 4:38 pm |
RNS |
PDS: 36-Month Overall Survival Rate announcement |
| 30th Sep 2024 7:00 am |
RNS |
Interim Results |
| 26th Sep 2024 7:00 am |
RNS |
Name change and AIM Rule 26 website |
